Professor Philip Molyneaux will give an oral presentation on the key efficacy and safety results from the Phase 2b CORAL trial of nalbuphine ER for the treatment of chronic cough in patients with ...

AURORA, Colo., Oct. 1, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, today announced that a human ...

CAMBRIDGE, Mass., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today ...

Materna Medical announced today that an interim sub-analysis comparing dilator user types from the Prospective On Market Patient-reported Outcomes for Milli (POMPOM) clinical study will be presented ...

A novel bispecific T cell engager for the treatment of solid tumors that express DARKFOX TM, a previously undiscovered antigen derived from an alternative open reading frame of FOXM1. Abstract number: ...

Shanchol, the oral cholera vaccine originally developed by Shantha Biotechnics, has received prequalification from the World Health Organization (WHO). This enables global procurement agencies such as ...

Leuven, Belgium. October 6, 2025. Onco3R Therapeutics, a clinical-stage immunology and oncology biotech company dedicated to transforming patients’ lives with best-in-class medicines, today announced ...

Made in Hyderabad oral cholera vaccine Shanchol, originally developed by Shantha Biotechnics and whose production resumed recently under a new management, has received World Health Organization (WHO) ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies. 1 Icotrokinra also showed ...

Oral melanoma is a rare cancer that forms in the mucosal tissues of the mouth. There may be no early symptoms, or a person may notice an area that is black or brown, with areas of gray, red, purple, ...

Kristen Stewart was an early choice for Bella, but Robert Pattinson was a "dark horse" for Edward. The fan reception was like "Beatlemania," with extreme security measures needed on set as the ...

HONG KONG, Sept. 9, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) announced that data from a Phase Ib/II clinical study evaluating the combination of cadonilimab and pulocimab (an anti-VEGFR-2 antibody) ...